;PMID: 8060487
;source_file_1922.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..40] = [t:0..40]
;1)sentence:[e:46..223] = [t:46..223]
;2)section:[e:227..295] = [t:227..295]
;3)section:[e:299..382] = [t:299..382]
;4)sentence:[e:386..529] = [t:386..529]
;5)sentence:[e:530..724] = [t:530..724]
;6)sentence:[e:725..929] = [t:725..929]
;7)sentence:[e:931..1172] = [t:931..1172]
;8)sentence:[e:1174..1346] = [t:1174..1346]
;9)sentence:[e:1347..1410] = [t:1347..1410]
;10)sentence:[e:1412..1526] = [t:1412..1526]
;11)sentence:[e:1527..1684] = [t:1527..1684]
;12)sentence:[e:1685..1794] = [t:1685..1794]
;13)sentence:[e:1796..1960] = [t:1796..1960]
;14)sentence:[e:1961..2112] = [t:1961..2112]
;15)sentence:[e:2113..2244] = [t:2113..2244]
;16)sentence:[e:2245..2500] = [t:2245..2500]
;17)sentence:[e:2501..2690] = [t:2501..2690]
;18)section:[e:2694..2738] = [t:2694..2738]

;section 0 Span:0..40
;J Mol Endocrinol. 1994 Apr;12(2):239-49.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..5] Mol) (NNP:[6..16] Endocrinol) (.:[16..17] .)
        (CD:[18..22] 1994) (CC:[23..30] Apr;12-LRB-) (CD:[30..31] 2)
        (-RRB-:[31..32] -RRB-) (::[32..33] :) (CD:[33..36] 239)
        (CD:[36..39] -49) (.:[39..40] .)))

;sentence 1 Span:46..223
;Differential regulation of cholesterol side-chain cleavage (P450scc) and 
;aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP
;in  human granulosa cells.
;[73..104]:cyp450:"cholesterol side-chain cleavage"
;[106..113]:cyp450:"P450scc"
;[120..152]:substance:"aromatase (P450arom) enzyme mRNA"
;[167..181]:substance:"gonadotrophins"
;[186..196]:substance:"cyclic AMP"
(SENT
  (NP-HLN
    (NP (JJ:[46..58] Differential) (NN:[59..69] regulation))
    (PP (IN:[70..72] of)
      (NP
        (NP
          (NP (NN:[73..84] cholesterol)
            (NML (NN:[85..89] side) (HYPH:[89..90] -) (NN:[90..95] chain))
            (NN:[96..104] cleavage))
          (NP (-LRB-:[105..106] -LRB-) (NN:[106..113] P450scc)
              (-RRB-:[113..114] -RRB-)))
        (CC:[115..118] and)
        (NP
          
          (NML
            (NML (NN:[120..129] aromatase))
            (NML (-LRB-:[130..131] -LRB-) (NN:[131..139] P450arom)
                 (-RRB-:[139..140] -RRB-)))
          (NN:[141..147] enzyme) (NN:[148..152] mRNA)
          (NN:[153..163] expression))))
    (PP (IN:[164..166] by)
      (NP
        (NP (NNS:[167..181] gonadotrophins))
        (CC:[182..185] and)
        (NP (JJ:[186..192] cyclic) (NN:[193..196] AMP))))
    (PP-LOC (IN:[197..199] in)
      (NP (JJ:[201..206] human) (NN:[207..216] granulosa) (NNS:[217..222] cells)))
    (.:[222..223] .)))

;section 2 Span:227..295
;Yong EL, Hillier SG, Turner M, Baird DT, Ng SC, Bongso A, Ratnam SS.
(SEC
  (FRAG (NNP:[227..231] Yong) (NNP:[232..234] EL) (,:[234..235] ,)
        (NNP:[236..243] Hillier) (NNP:[244..246] SG) (,:[246..247] ,)
        (NNP:[248..254] Turner) (NNP:[255..257] M,) (NNP:[258..263] Baird)
        (NNP:[264..266] DT) (,:[266..267] ,) (NNP:[268..270] Ng)
        (NNP:[271..273] SC) (,:[273..274] ,) (NNP:[275..281] Bongso)
        (NNP:[282..283] A) (,:[283..284] ,) (NNP:[285..291] Ratnam)
        (NNP:[292..294] SS) (.:[294..295] .)))

;section 3 Span:299..382
;Department of Obstetrics and Gynaecology, National University Hospital, 
;Singapore.
(SEC
  (FRAG (NNP:[299..309] Department) (IN:[310..312] of)
        (NNP:[313..323] Obstetrics) (CC:[324..327] and)
        (NNP:[328..339] Gynaecology) (,:[339..340] ,) (NNP:[341..349] National)
        (NNP:[350..360] University) (NNP:[361..369] Hospital) (,:[369..370] ,)
        (NNP:[372..381] Singapore) (.:[381..382] .)))

;sentence 4 Span:386..529
;The co-ordinated biosynthesis of progesterone and oestradiol in the human
;ovary  is critical for reproductive cyclicity and eventual pregnancy.
;[419..431]:substance:"progesterone"
;[436..446]:substance:"oestradiol"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[386..389] The)
        (ADJP (AFX:[390..392] co) (HYPH:[392..393] -) (JJ:[393..402] ordinated))
        (NN:[403..415] biosynthesis))
      (PP (IN:[416..418] of)
        (NP (NN:[419..431] progesterone) (CC:[432..435] and)
            (NN:[436..446] oestradiol)))
      (PP-LOC (IN:[447..449] in)
        (NP (DT:[450..453] the) (JJ:[454..459] human) (NN:[460..465] ovary))))
    (VP (VBZ:[467..469] is)
      (ADJP-PRD (JJ:[470..478] critical))
      (PP (IN:[479..482] for)
        (NP
          (NP (JJ:[483..495] reproductive) (NN:[496..505] cyclicity))
          (CC:[506..509] and)
          (NP (JJ:[510..518] eventual) (NN:[519..528] pregnancy)))))
    (.:[528..529] .)))

;sentence 5 Span:530..724
;The crucial  regulatory enzymes for progesterone and oestradiol biosynthesis
;in granulosa  cells are the cholesterol side-chain cleavage (P450scc) and
;aromatase (P450arom)  enzymes respectively.
;[554..561]:cyp450:"enzymes"
;[566..578]:substance:"progesterone"
;[583..593]:substance:"oestradiol"
;[635..676]...[703..710]:cyp450:"cholesterol side-chain cleavage
;(P450scc)"..."enzymes"
;[681..710]:cyp450:"aromatase (P450arom)  enzymes"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[530..533] The) (JJ:[534..541] crucial) (JJ:[543..553] regulatory)
          (NNS:[554..561] enzymes))
      (PP (IN:[562..565] for)
        (NP
          (NP (NN:[566..578] progesterone)
            (NML-2 (-NONE-:[578..578] *P*)))
          (CC:[579..582] and)
          (NP (NN:[583..593] oestradiol)
            (NML-2 (NN:[594..606] biosynthesis)))))
      (PP-LOC (IN:[607..609] in)
        (NP (NN:[610..619] granulosa) (NNS:[621..626] cells))))
    (VP (VBP:[627..630] are)
      (NP-PRD (DT:[631..634] the)
        (NP
          (NML
            (NML
              (NML (NN:[635..646] cholesterol)
                (NML (NN:[647..651] side) (HYPH:[651..652] -)
                     (NN:[652..657] chain))
                (NN:[658..666] cleavage))
              (NML (-LRB-:[667..668] -LRB-) (NN:[668..675] P450scc)
                   (-RRB-:[675..676] -RRB-)))
            (NML-1 (-NONE-:[676..676] *P*)))
          (CC:[677..680] and)
          (NML
            (NML
              (NML (NN:[681..690] aromatase))
              (NML (-LRB-:[691..692] -LRB-) (NN:[692..700] P450arom)
                   (-RRB-:[700..701] -RRB-)))
            (NML-1 (NNS:[703..710] enzymes)))))
      (ADVP (RB:[711..723] respectively)))
    (.:[723..724] .)))

;sentence 6 Span:725..929
;We utilized the cDNA sequences encoding P450arom and  P450scc to examine the
;roles of FSH and LH, and their intracellular second  messenger, cyclic AMP
;(cAMP), in regulating steroidogenic gene expression.
;[741..745]:substance:"cDNA"
;[765..773]:cyp450:"P450arom"
;[779..786]:cyp450:"P450scc"
;[811..814]:substance:"FSH"
;[819..821]:substance:"LH"
;[855..864]:substance:"messenger"
;[866..876]:substance:"cyclic AMP"
;[878..882]:substance:"cAMP"
(SENT
  (S
    (NP-SBJ (PRP:[725..727] We))
    (VP (VBD:[728..736] utilized)
      (NP
        (NP (DT:[737..740] the) (NN:[741..745] cDNA) (NNS:[746..755] sequences))
        (VP (VBG:[756..764] encoding)
          (NP (NN:[765..773] P450arom) (CC:[774..777] and)
              (NN:[779..786] P450scc))))
      (S-PRP
        (NP-SBJ (-NONE-:[786..786] *))
        (VP (TO:[787..789] to)
          (VP (VB:[790..797] examine)
            (NP
              (NP (DT:[798..801] the) (NNS:[802..807] roles))
              (PP (IN:[808..810] of)
                (NP
                  (NP (NN:[811..814] FSH) (CC:[815..818] and) (NN:[819..821] LH))
                  (,:[821..822] ,) (CC:[823..826] and)
                  (NP
                    (NP (PRP$:[827..832] their) (JJ:[833..846] intracellular)
                        (JJ:[847..853] second) (NN:[855..864] messenger))
                    (,:[864..865] ,)
                    (NP
                      (NP (JJ:[866..872] cyclic) (NN:[873..876] AMP))
                      (NP (-LRB-:[877..878] -LRB-) (NN:[878..882] cAMP)
                          (-RRB-:[882..883] -RRB-))))))
              (,:[883..884] ,)
              (PP (IN:[885..887] in)
                (S-NOM
                  (NP-SBJ (-NONE-:[887..887] *))
                  (VP (VBG:[888..898] regulating)
                    (NP (JJ:[899..912] steroidogenic) (NN:[913..917] gene)
                        (NN:[918..928] expression))))))))))
    (.:[928..929] .)))

;sentence 7 Span:931..1172
;Mature granulosa cells (aspirated before the onset of the endogenous LH
;surge)  and granulosa lutein cells (obtained after an ovulatory dose of human
;chorionic  gonadotrophin) were cultured for 4 days with FSH, LH or dibutyryl
;cAMP (dbcAMP).
;[1000..1002]:substance:"LH"
;[1081..1105]:substance:"chorionic  gonadotrophin"
;[1125..1126]:quantitative-value:"4"
;[1127..1131]:quantitative-units:"days"
;[1137..1140]:substance:"FSH"
;[1142..1144]:substance:"LH"
;[1148..1162]:substance:"dibutyryl cAMP"
;[1164..1170]:substance:"dbcAMP"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[931..937] Mature) (NN:[938..947] granulosa)
          (NNS:[948..953] cells)
        (PRN (-LRB-:[954..955] -LRB-)
          (VP (VBN:[955..964] aspirated)
            (NP (-NONE-:[964..964] *))
            (PP-TMP (IN:[965..971] before)
              (NP
                (NP (DT:[972..975] the) (NN:[976..981] onset))
                (PP (IN:[982..984] of)
                  (NP (DT:[985..988] the) (JJ:[989..999] endogenous)
                      (NN:[1000..1002] LH) (NN:[1003..1008] surge))))))
          (-RRB-:[1008..1009] -RRB-)))
      (CC:[1011..1014] and)
      (NP (NN:[1015..1024] granulosa) (NN:[1025..1031] lutein)
          (NNS:[1032..1037] cells)
        (PRN (-LRB-:[1038..1039] -LRB-)
          (VP (VBN:[1039..1047] obtained)
            (NP (-NONE-:[1047..1047] *))
            (PP (IN:[1048..1053] after)
              (NP
                (NP (DT:[1054..1056] an) (JJ:[1057..1066] ovulatory)
                    (NN:[1067..1071] dose))
                (PP (IN:[1072..1074] of)
                  (NP (JJ:[1075..1080] human)
                     (JJ:[1081..1090] chorionic) (NN:[1092..1105] gonadotrophin))))))
          (-RRB-:[1105..1106] -RRB-))))
    (VP (VBD:[1107..1111] were)
      (VP (VBN:[1112..1120] cultured)
        (NP-1 (-NONE-:[1120..1120] *))
        (PP (IN:[1121..1124] for)
          (NP (CD:[1125..1126] 4) (NNS:[1127..1131] days)))
        (PP (IN:[1132..1136] with)
          (NP
            (NP (NN:[1137..1140] FSH))
            (,:[1140..1141] ,)
            (NP (NN:[1142..1144] LH))
            (CC:[1145..1147] or)
            (NP
              (NP (NN:[1148..1157] dibutyryl) (NN:[1158..1162] cAMP))
              (NP (-LRB-:[1163..1164] -LRB-) (NN:[1164..1170] dbcAMP)
                  (-RRB-:[1170..1171] -RRB-)))))))
    (.:[1171..1172] .)))

;sentence 8 Span:1174..1346
;After the period of culture, total RNA was extracted from granulosa cells and
; Northern analyses were performed utilizing 32P-labelled cDNAs encoding
;P450arom  and P450scc.
;[1209..1212]:substance:"RNA"
;[1296..1299]:substance:"32P"
;[1309..1314]:substance:"cDNAs"
;[1324..1332]:cyp450:"P450arom"
;[1338..1345]:cyp450:"P450scc"
(SENT
  (S
    (S
      (PP-TMP (IN:[1174..1179] After)
        (NP
          (NP (DT:[1180..1183] the) (NN:[1184..1190] period))
          (PP (IN:[1191..1193] of)
            (NP (NN:[1194..1201] culture)))))
      (,:[1201..1202] ,)
      (NP-SBJ-1 (JJ:[1203..1208] total) (NN:[1209..1212] RNA))
      (VP (VBD:[1213..1216] was)
        (VP (VBN:[1217..1226] extracted)
          (NP-1 (-NONE-:[1226..1226] *))
          (PP (IN:[1227..1231] from)
            (NP (NN:[1232..1241] granulosa) (NNS:[1242..1247] cells))))))
    (CC:[1248..1251] and)
    (S
      (NP-SBJ-2 (JJ:[1253..1261] Northern) (NNS:[1262..1270] analyses))
      (VP (VBD:[1271..1275] were)
        (VP (VBN:[1276..1285] performed)
          (NP-2 (-NONE-:[1285..1285] *))
          (S-MNR
            (NP-SBJ (-NONE-:[1285..1285] *))
            (VP (VBG:[1286..1295] utilizing)
              (NP
                (NP
                  (ADJP (NN:[1296..1299] 32P) (HYPH:[1299..1300] -)
                        (VBN:[1300..1308] labelled))
                  (NNS:[1309..1314] cDNAs))
                (VP (VBG:[1315..1323] encoding)
                  (NP (NN:[1324..1332] P450arom) (CC:[1334..1337] and)
                      (NN:[1338..1345] P450scc)))))))))
    (.:[1345..1346] .)))

;sentence 9 Span:1347..1410
;Spent culture media were analysed for steroid and cAMP content.
;[1385..1392]:substance:"steroid"
;[1397..1401]:substance:"cAMP"
(SENT
  (S
    (NP-SBJ-2 (VBN:[1347..1352] Spent) (NN:[1353..1360] culture)
              (NNS:[1361..1366] media))
    (VP (VBD:[1367..1371] were)
      (VP (VBN:[1372..1380] analysed)
        (NP-2 (-NONE-:[1380..1380] *))
        (PP (IN:[1381..1384] for)
          (NP
            (NP (JJ:[1385..1392] steroid)
              (NML-1 (-NONE-:[1392..1392] *P*)))
            (CC:[1393..1396] and)
            (NP (NN:[1397..1401] cAMP)
              (NML-1 (NN:[1402..1409] content)))))))
    (.:[1409..1410] .)))

;sentence 10 Span:1412..1526
;Both FSH and LH strongly stimulated P450arom mRNA expression and oestradiol 
;production in mature granulosa cells.
;[1417..1420]:substance:"FSH"
;[1425..1427]:substance:"LH"
;[1448..1461]:substance:"P450arom mRNA"
;[1477..1487]:substance:"oestradiol"
(SENT
  (S
    (NP-SBJ (CC:[1412..1416] Both) (NN:[1417..1420] FSH) (CC:[1421..1424] and)
            (NN:[1425..1427] LH))
    (ADVP (RB:[1428..1436] strongly))
    (VP (VBD:[1437..1447] stimulated)
      (NP
        (NP
           (NN:[1448..1456] P450arom) (NN:[1457..1461] mRNA)
          (NN:[1462..1472] expression))
        (CC:[1473..1476] and)
        (NP (NN:[1477..1487] oestradiol) (NN:[1489..1499] production)))
      (PP-LOC (IN:[1500..1502] in)
        (NP (JJ:[1503..1509] mature) (NN:[1510..1519] granulosa)
            (NNS:[1520..1525] cells))))
    (.:[1525..1526] .)))

;sentence 11 Span:1527..1684
;On the other hand, P450scc mRNA expression  and progesterone biosynthesis
;were weakly induced by FSH; maximal synthesis  occurred only in the presence
;of LH.
;[1546..1558]:substance:"P450scc mRNA"
;[1575..1587]:substance:"progesterone"
;[1624..1627]:substance:"FSH"
;[1681..1683]:substance:"LH"
(SENT
  (S
    (S
      (PP (IN:[1527..1529] On)
        (NP (DT:[1530..1533] the) (JJ:[1534..1539] other) (NN:[1540..1544] hand)))
      (,:[1544..1545] ,)
      (NP-SBJ-1
        (NP
           (NN:[1546..1553] P450scc) (NN:[1554..1558] mRNA)
          (NN:[1559..1569] expression))
        (CC:[1571..1574] and)
        (NP (NN:[1575..1587] progesterone) (NN:[1588..1600] biosynthesis)))
      (VP (VBD:[1601..1605] were)
        (ADVP (RB:[1606..1612] weakly))
        (VP (VBN:[1613..1620] induced)
          (NP-1 (-NONE-:[1620..1620] *))
          (PP (IN:[1621..1623] by)
            (NP-LGS (NN:[1624..1627] FSH))))))
    (::[1627..1628] ;)
    (S
      (NP-SBJ (JJ:[1629..1636] maximal) (NN:[1637..1646] synthesis))
      (VP (VBD:[1648..1656] occurred)
        (PP (RB:[1657..1661] only) (IN:[1662..1664] in)
          (NP
            (NP (DT:[1665..1668] the) (NN:[1669..1677] presence))
            (PP (IN:[1678..1680] of)
              (NP (NN:[1681..1683] LH)))))))
    (.:[1683..1684] .)))

;sentence 12 Span:1685..1794
;With both gonadotrophins at equivalent  concentrations, LH generated a
;30-fold higher level of cAMP than FSH.
;[1695..1709]:substance:"gonadotrophins"
;[1741..1743]:substance:"LH"
;[1756..1770]:quantitative-value:"30-fold higher"
;[1780..1784]:substance:"cAMP"
;[1790..1793]:substance:"FSH"
(SENT
  (S
    (PP (IN:[1685..1689] With)
      (NP
        (NP (DT:[1690..1694] both) (NNS:[1695..1709] gonadotrophins))
        (PP (IN:[1710..1712] at)
          (NP (JJ:[1713..1723] equivalent) (NNS:[1725..1739] concentrations)))))
    (,:[1739..1740] ,)
    (NP-SBJ (NN:[1741..1743] LH))
    (VP (VBD:[1744..1753] generated)
      (NP
        (NP (DT:[1754..1755] a)
          (ADJP
            (NML-EXT (CD:[1756..1758] 30) (HYPH:[1758..1759] -)
                     (RB:[1759..1763] fold))
            (JJR:[1764..1770] higher))
          (NN:[1771..1776] level))
        (PP (IN:[1777..1779] of)
          (NP (NN:[1780..1784] cAMP)))
        (PP (IN:[1785..1789] than)
          (NP (NN:[1790..1793] FSH)))))
    (.:[1793..1794] .)))

;sentence 13 Span:1796..1960
;Furthermore, the differential effects of FSH and LH on P450 mRNA expression
;were  reproduced by the presence of low and high concentrations of dbcAMP 
;respectively.
;[1837..1840]:substance:"FSH"
;[1845..1847]:substance:"LH"
;[1851..1860]:substance:"P450 mRNA"
;[1939..1945]:substance:"dbcAMP"
(SENT
  (S
    (ADVP (RB:[1796..1807] Furthermore))
    (,:[1807..1808] ,)
    (NP-SBJ-2
      (NP (DT:[1809..1812] the) (JJ:[1813..1825] differential)
          (NNS:[1826..1833] effects))
      (PP (IN:[1834..1836] of)
        (NP (NN:[1837..1840] FSH) (CC:[1841..1844] and) (NN:[1845..1847] LH)))
      (PP (IN:[1848..1850] on)
        (NP
           (NN:[1851..1855] P450) (NN:[1856..1860] mRNA)
          (NN:[1861..1871] expression))))
    (VP (VBD:[1872..1876] were)
      (VP (VBN:[1878..1888] reproduced)
        (NP-2 (-NONE-:[1888..1888] *))
        (PP (IN:[1889..1891] by)
          (NP
            (NP (DT:[1892..1895] the) (NN:[1896..1904] presence))
            (PP (IN:[1905..1907] of)
              (NP
                (NP
                  (NP (JJ:[1908..1911] low)
                    (NML-1 (-NONE-:[1911..1911] *P*)))
                  (CC:[1912..1915] and)
                  (NP (JJ:[1916..1920] high)
                    (NML-1 (NNS:[1921..1935] concentrations))))
                (PP (IN:[1936..1938] of)
                  (NP (NN:[1939..1945] dbcAMP)))))))
        (ADVP (RB:[1947..1959] respectively))))
    (.:[1959..1960] .)))

;sentence 14 Span:1961..2112
;LH (and high levels of dbcAMP) increased P450arom mRNA expression  in mature
;granulosa cells but inhibited its accumulation in granulosa lutein  cells.
;[1961..1963]:substance:"LH"
;[1984..1990]:substance:"dbcAMP"
;[2002..2015]:substance:"P450arom mRNA"
(SENT
  (S
    (NP-SBJ (NN:[1961..1963] LH)
      (PRN (-LRB-:[1964..1965] -LRB-)
        (FRAG (CC:[1965..1968] and)
          (NP
            (NP (JJ:[1969..1973] high) (NNS:[1974..1980] levels))
            (PP (IN:[1981..1983] of)
              (NP (NN:[1984..1990] dbcAMP)))))
        (-RRB-:[1990..1991] -RRB-)))
    (VP
      (VP (VBD:[1992..2001] increased)
        (NP
           (NN:[2002..2010] P450arom) (NN:[2011..2015] mRNA)
          (NN:[2016..2026] expression))
        (PP-LOC (IN:[2028..2030] in)
          (NP (JJ:[2031..2037] mature) (NN:[2038..2047] granulosa)
              (NNS:[2048..2053] cells))))
      (CC:[2054..2057] but)
      (VP (VBD:[2058..2067] inhibited)
        (NP (PRP$:[2068..2071] its) (NN:[2072..2084] accumulation))
        (PP-LOC (IN:[2085..2087] in)
          (NP (NN:[2088..2097] granulosa) (NN:[2098..2104] lutein)
              (NNS:[2106..2111] cells)))))
    (.:[2111..2112] .)))

;sentence 15 Span:2113..2244
;In contrast, it stimulated P450scc mRNA expression and progesterone 
;synthesis in both mature granulosa and granulosa lutein cells.
;[2140..2152]:substance:"P450scc mRNA"
;[2168..2180]:substance:"progesterone"
(SENT
  (S
    (PP (IN:[2113..2115] In)
      (NP (NN:[2116..2124] contrast)))
    (,:[2124..2125] ,)
    (NP-SBJ (PRP:[2126..2128] it))
    (VP (VBD:[2129..2139] stimulated)
      (NP
        (NP
           (NN:[2140..2147] P450scc) (NN:[2148..2152] mRNA)
          (NN:[2153..2163] expression))
        (CC:[2164..2167] and)
        (NP (NN:[2168..2180] progesterone) (NN:[2182..2191] synthesis)))
      (PP-LOC (IN:[2192..2194] in)
        (NP (CC:[2195..2199] both)
          (NP (JJ:[2200..2206] mature) (NN:[2207..2216] granulosa))
          (CC:[2217..2220] and)
          (NP (NN:[2221..2230] granulosa) (NN:[2231..2237] lutein)
              (NNS:[2238..2243] cells)))))
    (.:[2243..2244] .)))

;sentence 16 Span:2245..2500
;Therefore,  FSH/low cAMP levels stimulated P450arom gene expression and
;oestradiol  production, while LH/high cAMP levels maximally induced P450scc
;gene expression  and function, in a development-related manner consistent
;with steroid production  in vivo.
;[2257..2260]:substance:"FSH"
;[2265..2269]:substance:"cAMP"
;[2317..2327]:substance:"oestradiol"
;[2347..2349]:substance:"LH"
;[2355..2359]:substance:"cAMP"
;[2472..2479]:substance:"steroid"
(SENT
  (S
    (ADVP (RB:[2245..2254] Therefore))
    (,:[2254..2255] ,)
    (S
      (NP-SBJ
        (NP (NN:[2257..2260] FSH))
        (SYM:[2260..2261] /)
        (NP (JJ:[2261..2264] low) (NN:[2265..2269] cAMP)
            (NNS:[2270..2276] levels)))
      (VP (VBD:[2277..2287] stimulated)
        (NP
          (NP (NN:[2288..2296] P450arom) (NN:[2297..2301] gene)
              (NN:[2302..2312] expression))
          (CC:[2313..2316] and)
          (NP (NN:[2317..2327] oestradiol) (NN:[2329..2339] production)))
        (,:[2339..2340] ,)
        (SBAR-ADV (IN:[2341..2346] while)
          (S
            (NP-SBJ
              (NP (NN:[2347..2349] LH))
              (SYM:[2349..2350] /)
              (NP (JJ:[2350..2354] high) (NN:[2355..2359] cAMP)
                  (NNS:[2360..2366] levels)))
            (ADVP (RB:[2367..2376] maximally))
            (VP (VBD:[2377..2384] induced)
              (NP
                (NP
                  (NML-1 (NN:[2385..2392] P450scc) (NN:[2393..2397] gene))
                  (NN:[2398..2408] expression))
                (CC:[2410..2413] and)
                (NP
                  (NML-1 (-NONE-:[2413..2413] *P*))
                  (NN:[2414..2422] function)))
              (,:[2422..2423] ,)
              (PP-MNR (IN:[2424..2426] in)
                (NP
                  (NP (DT:[2427..2428] a)
                    (ADJP (NN:[2429..2440] development) (HYPH:[2440..2441] -)
                          (VBN:[2441..2448] related))
                    (NN:[2449..2455] manner))
                  (ADJP (JJ:[2456..2466] consistent)
                    (PP (IN:[2467..2471] with)
                      (NP
                        (NP (JJ:[2472..2479] steroid)
                            (NN:[2480..2490] production))
                        (ADJP (FW:[2492..2494] in) (FW:[2495..2499] vivo))))))))))))
    (.:[2499..2500] .)))

;sentence 17 Span:2501..2690
;These findings support the hypothesis that one set of genes (like  P450arom)
;in human granulosa cells is regulated by FSH/low cAMP levels and  another
;(like P450scc) by LH/high cAMP levels.
;[2619..2622]:substance:"FSH"
;[2627..2631]:substance:"cAMP"
;[2670..2672]:substance:"LH"
;[2678..2682]:substance:"cAMP"
(SENT
  (S
    (NP-SBJ (DT:[2501..2506] These) (NNS:[2507..2515] findings))
    (VP (VBP:[2516..2523] support)
      (NP (DT:[2524..2527] the) (NN:[2528..2538] hypothesis)
        (SBAR (IN:[2539..2543] that)
          (S
            (S
              (NP-SBJ-4=1
                (NP (CD:[2544..2547] one) (NN:[2548..2551] set))
                (PP (IN:[2552..2554] of)
                  (NP (NNS:[2555..2560] genes)))
                (PRN (-LRB-:[2561..2562] -LRB-)
                  (PP (IN:[2562..2566] like)
                    (NP (NN:[2568..2576] P450arom)))
                  (-RRB-:[2576..2577] -RRB-))
                (PP-LOC (IN:[2578..2580] in)
                  (NP (JJ:[2581..2586] human) (NN:[2587..2596] granulosa)
                      (NNS:[2597..2602] cells))))
              (VP=2 (VBZ:[2603..2605] is)
                (VP (VBN:[2606..2615] regulated)
                  (NP-4 (-NONE-:[2615..2615] *))
                  (PP-MNR=3 (IN:[2616..2618] by)
                    (NP
                      (NP (NN:[2619..2622] FSH))
                      (SYM:[2622..2623] /)
                      (NP (JJ:[2623..2626] low) (NN:[2627..2631] cAMP)
                          (NNS:[2632..2638] levels)))))))
            (CC:[2639..2642] and)
            (S
              (NP-SBJ=1 (DT:[2644..2651] another)
                (PRN (-LRB-:[2652..2653] -LRB-)
                  (PP (IN:[2653..2657] like)
                    (NP (NN:[2658..2665] P450scc)))
                  (-RRB-:[2665..2666] -RRB-)))
              (VP=2
                (PP-MNR=3 (IN:[2667..2669] by)
                  (NP
                    (NP (NN:[2670..2672] LH))
                    (SYM:[2672..2673] /)
                    (NP (JJ:[2673..2677] high) (NN:[2678..2682] cAMP)
                        (NNS:[2683..2689] levels))))))))))
    (.:[2689..2690] .)))

;section 18 Span:2694..2738
;PMID: 8060487 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2694..2698] PMID) (::[2698..2699] :) (CD:[2700..2707] 8060487)
        (NN:[2708..2709] -LSB-) (NNP:[2709..2715] PubMed) (::[2716..2717] -)
        (NN:[2718..2725] indexed) (IN:[2726..2729] for)
        (NNP:[2730..2737] MEDLINE) (-RRB-:[2737..2738] -RSB-)))
